Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma.
Eur J Endocrinol. 2022 Jul 19;187(3):R27-R40. doi: 10.1530/EJE-22-0260. Print 2022 Sep 1.
Eur J Endocrinol. 2022.
PMID: 35695575
Review.
Adrenocortical carcinoma (ACC) accounts for a minority of all malignant tumors in adults. ...We consider that the concomitant presence of the following features characterizes a cohort of patients at low risk of recurrence, (i) R0 resection (microscopically free marg …
Adrenocortical carcinoma (ACC) accounts for a minority of all malignant tumors in adults. ...We consider that the concomitant presenc …
European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma.
Gaujoux S, Mihai R; joint working group of ESES and ENSAT.
Gaujoux S, et al.
Br J Surg. 2017 Mar;104(4):358-376. doi: 10.1002/bjs.10414.
Br J Surg. 2017.
PMID: 28199015
BACKGROUND: Radical surgery provides the best chance of cure for adrenocortical carcinoma (ACC), but perioperative surgical care for these patients is yet to be standardized. ...Evidence and recommendations were classified according to the Grading of Recommen …
BACKGROUND: Radical surgery provides the best chance of cure for adrenocortical carcinoma (ACC), but perioperative surgical care …
Item in Clipboard
Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma.
Baudin E, Pellegriti G, Bonnay M, Penfornis A, Laplanche A, Vassal G, Schlumberger M.
Baudin E, et al.
Cancer. 2001 Sep 15;92(6):1385-92. doi: 10.1002/1097-0142(20010915)92:6<1385::aid-cncr1461>3.0.co;2-2.
Cancer. 2001.
PMID: 11745214
Oral o,p'DDD was given in three separate doses up to at least 6-12 g per day together with substitutive adrenal therapy. Plasma o,p'DDD levels were measured using high-performance liquid chromatography every 2 months. ...These tumor responses were observed among the …
Oral o,p'DDD was given in three separate doses up to at least 6-12 g per day together with substitutive adrenal therapy. Plasm …
Item in Clipboard
Cite
Cite